357 related articles for article (PubMed ID: 34101334)
1. Impact of errors in spot size and spot position in robustly optimized pencil beam scanning proton-based stereotactic body radiation therapy (SBRT) lung plans.
Rana S; Rosenfeld AB
J Appl Clin Med Phys; 2021 Jul; 22(7):147-154. PubMed ID: 34101334
[TBL] [Abstract][Full Text] [Related]
2. Small spot size versus large spot size: Effect on plan quality for lung cancer in pencil beam scanning proton therapy.
Rana S; Rosenfeld AB
J Appl Clin Med Phys; 2022 Feb; 23(2):e13512. PubMed ID: 34989458
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of dose-averaged linear energy transfer (LET
Rana S; Traneus E; Jackson M; Tran L; Rosenfeld AB
Med Phys; 2022 May; 49(5):3444-3456. PubMed ID: 35194809
[TBL] [Abstract][Full Text] [Related]
4. Impact of proton dose calculation algorithms on the interplay effect in PBS proton based SBRT lung plans.
Rana S; Rosenfeld AB
Biomed Phys Eng Express; 2021 May; 7(4):. PubMed ID: 34029212
[No Abstract] [Full Text] [Related]
5. Cyclotron and linear accelerator generated scanning proton beams for lung cancer SBRT: Interplay effects and mitigations.
Liu CW; Kolano AM; Gray T; Stephans KL; Videtic GMM; Farr JB; Xia P
Med Phys; 2024 Jun; 51(6):3985-3994. PubMed ID: 38683935
[TBL] [Abstract][Full Text] [Related]
6. Robust Optimization of SBRT Planning for Patients With Early Stage Non-Small Cell Lung Cancer.
Shang H; Pu Y; Wang Y
Technol Cancer Res Treat; 2020; 19():1533033820916505. PubMed ID: 32314663
[TBL] [Abstract][Full Text] [Related]
7. Limited Impact of Setup and Range Uncertainties, Breathing Motion, and Interplay Effects in Robustly Optimized Intensity Modulated Proton Therapy for Stage III Non-small Cell Lung Cancer.
Inoue T; Widder J; van Dijk LV; Takegawa H; Koizumi M; Takashina M; Usui K; Kurokawa C; Sugimoto S; Saito AI; Sasai K; Van't Veld AA; Langendijk JA; Korevaar EW
Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):661-9. PubMed ID: 27681763
[TBL] [Abstract][Full Text] [Related]
8. Impact of Spot Size and Spacing on the Quality of Robustly Optimized Intensity Modulated Proton Therapy Plans for Lung Cancer.
Liu C; Schild SE; Chang JY; Liao Z; Korte S; Shen J; Ding X; Hu Y; Kang Y; Keole SR; Sio TT; Wong WW; Sahoo N; Bues M; Liu W
Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):479-489. PubMed ID: 29550033
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of robust optimization in volumetric modulated arc therapy using 6 and 10 MV flattening filter-free beam therapy planning for lung stereotactic body radiation therapy with a breath-hold technique.
Miura H; Ozawa S; Doi Y; Nakao M; Kubo K; Kenjo M; Nagata Y
J Radiat Res; 2020 Jul; 61(4):575-585. PubMed ID: 32367109
[TBL] [Abstract][Full Text] [Related]
10. Superiority in Robustness of Multifield Optimization Over Single-Field Optimization for Pencil-Beam Proton Therapy for Oropharynx Carcinoma: An Enhanced Robustness Analysis.
Stützer K; Lin A; Kirk M; Lin L
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):738-749. PubMed ID: 29280468
[TBL] [Abstract][Full Text] [Related]
11. Exploratory Study of 4D versus 3D Robust Optimization in Intensity Modulated Proton Therapy for Lung Cancer.
Liu W; Schild SE; Chang JY; Liao Z; Chang YH; Wen Z; Shen J; Stoker JB; Ding X; Hu Y; Sahoo N; Herman MG; Vargas C; Keole S; Wong W; Bues M
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):523-533. PubMed ID: 26725727
[TBL] [Abstract][Full Text] [Related]
12. Investigating volumetric repainting to mitigate interplay effect on 4D robustly optimized lung cancer plans in pencil beam scanning proton therapy.
Rana S; Rosenfeld AB
J Appl Clin Med Phys; 2021 Mar; 22(3):107-118. PubMed ID: 33599391
[TBL] [Abstract][Full Text] [Related]
13. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
[TBL] [Abstract][Full Text] [Related]
14. Intensity-modulated proton therapy (IMPT) interplay effect evaluation of asymmetric breathing with simultaneous uncertainty considerations in patients with non-small cell lung cancer.
Shan J; Yang Y; Schild SE; Daniels TB; Wong WW; Fatyga M; Bues M; Sio TT; Liu W
Med Phys; 2020 Nov; 47(11):5428-5440. PubMed ID: 32964474
[TBL] [Abstract][Full Text] [Related]
15. Performance evaluation of adaptive aperture's static and dynamic collimation in a compact pencil beam scanning proton therapy system: A dosimetric comparison study for multiple disease sites.
Grewal HS; Ahmad S; Jin H
Med Dosim; 2021 Summer; 46(2):179-187. PubMed ID: 33279369
[TBL] [Abstract][Full Text] [Related]
16. An Analysis of Plan Robustness for Esophageal Tumors: Comparing Volumetric Modulated Arc Therapy Plans and Spot Scanning Proton Planning.
Warren S; Partridge M; Bolsi A; Lomax AJ; Hurt C; Crosby T; Hawkins MA
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):199-207. PubMed ID: 27084641
[TBL] [Abstract][Full Text] [Related]
17. Use of single-energy proton pencil beam scanning Bragg peak for intensity-modulated proton therapy FLASH treatment planning in liver-hypofractionated radiation therapy.
Wei S; Lin H; Shi C; Xiong W; Chen CC; Huang S; Press RH; Hasan S; Chhabra AM; Choi JI; Simone CB; Kang M
Med Phys; 2022 Oct; 49(10):6560-6574. PubMed ID: 35929404
[TBL] [Abstract][Full Text] [Related]
18. ITV-Based Robust Optimization for VMAT Planning of Stereotactic Body Radiation Therapy of Lung Cancer.
Liang X; Zheng D; Mamalui-Hunter M; Flampouri S; Hoppe BS; Mendenhall N; Li Z
Pract Radiat Oncol; 2019 Jan; 9(1):38-48. PubMed ID: 30138747
[TBL] [Abstract][Full Text] [Related]
19. Radiobiological and dosimetric impact of RayStation pencil beam and Monte Carlo algorithms on intensity-modulated proton therapy breast cancer plans.
Rana S; Greco K; Samuel EJJ; Bennouna J
J Appl Clin Med Phys; 2019 Aug; 20(8):36-46. PubMed ID: 31343826
[TBL] [Abstract][Full Text] [Related]
20. Is it beneficial to use apertures in proton radiosurgery with a scanning beam? A dosimetric comparison in neurinoma and meningioma patients.
Righetto R; Fellin F; Scartoni D; Amichetti M; Schwarz M; Amelio D; Farace P
J Appl Clin Med Phys; 2022 Feb; 23(2):e13459. PubMed ID: 34751499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
